The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma
- PMID: 17070231
- DOI: 10.1016/j.juro.2006.07.015
The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma
Abstract
Purpose: Studies have demonstrated increased time to progression when cytoreductive nephrectomy is performed for metastatic renal cell carcinoma. We evaluated the role of nephron sparing surgery in these patients.
Materials and methods: We selected all patients with pM1 renal cell carcinoma treated with nephron sparing surgery or radical nephrectomy, and all patients with pM0 renal cell carcinoma undergoing nephron sparing surgery for solitary kidney from 1970 to 2002 from the Mayo Clinic Nephrectomy Registry.
Results: We identified 16 patients who underwent nephron sparing surgery for pM1 renal cell carcinoma. Solitary kidney was present in 12, 3 had bilateral synchronous disease and 1 had elective nephron sparing surgery. Cancer specific survival rates at 1, 3 and 5 years were 81%, 49% and 49%, respectively. We identified 404 patients who underwent radical nephrectomy for pM1 renal cell carcinoma. Cancer specific survival rates at 1, 3 and 5 years were 51%, 21% and 13%, respectively. The pM1 nephron sparing surgery for solitary kidney cases were more likely to have early (33% vs 10%, p = 0.009) or late (50% vs 19%, p = 0.018) complications compared with pM1 radical nephrectomy cases. There were no significant differences in early (p = 0.475) or late (p = 0.350) complications between pM1 nephron sparing surgery cases and 139 pM0 nephron sparing surgery cases.
Conclusions: Cancer specific survival rates in pM1 nephron sparing surgery cases were comparable to pM1 radical nephrectomy cases. Although there were differences in early and late complications between the pM1 nephron sparing surgery and pM1 radical nephrectomy groups, there were no differences when compared with imperative pM0 nephron sparing surgery cases. This study demonstrates that nephron sparing surgery can achieve adequate cytoreductive therapy while preserving renal function, with postoperative complication rates similar to those of pM0 nephron sparing surgery cases.
Similar articles
-
Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.Scand J Urol Nephrol. 2007;41(1):10-3. doi: 10.1080/00365590600911225. Scand J Urol Nephrol. 2007. PMID: 17366096
-
Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.J Urol. 1998 Apr;159(4):1156-60. J Urol. 1998. PMID: 9507821 Clinical Trial.
-
Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.J Urol. 2008 Jan;179(1):71-4; discussion 74. doi: 10.1016/j.juro.2007.08.165. Epub 2007 Nov 12. J Urol. 2008. PMID: 17997423
-
Nephron sparing surgery for renal tumors: indications, techniques and outcomes.J Urol. 2001 Jul;166(1):6-18. J Urol. 2001. PMID: 11435813 Review.
-
[Recent advances in nephron-sparing surgery for renal cell carcinoma].Gan To Kagaku Ryoho. 2002 Oct;29(10):1726-31. Gan To Kagaku Ryoho. 2002. PMID: 12402421 Review. Japanese.
Cited by
-
Partial nephrectomy in the setting of metastatic renal cell carcinoma.J Urol. 2014 Jul;192(1):36-42. doi: 10.1016/j.juro.2014.01.086. Epub 2014 Feb 8. J Urol. 2014. PMID: 24518767 Free PMC article.
-
Outlining the limits of partial nephrectomy.Transl Androl Urol. 2015 Jun;4(3):294-300. doi: 10.3978/j.issn.2223-4683.2015.06.04. Transl Androl Urol. 2015. PMID: 26236649 Free PMC article.
-
Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy.Nat Rev Urol. 2009 Jul;6(7):375-83. doi: 10.1038/nrurol.2009.102. Epub 2009 Jun 16. Nat Rev Urol. 2009. PMID: 19528960 Review.
-
[Metastatic renal cell carcinoma: therapeutic concepts for non-medicinal treatment].Urologe A. 2011 Jul;50(7):853-60. doi: 10.1007/s00120-011-2599-2. Urologe A. 2011. PMID: 21678107 Review. German.
-
Complete remission of renal cell carcinoma with lung carcinomatous lymphangiosis after primary therapy with immune checkpoint inhibitors followed by partial nephrectomy for surgical consolidation.IJU Case Rep. 2022 Mar 25;5(3):168-171. doi: 10.1002/iju5.12427. eCollection 2022 May. IJU Case Rep. 2022. PMID: 35509785 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical